http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103145663-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6969f53094513a69feb2c3e480c8cf60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D295-088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C315-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C317-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
filingDate 2013-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ab6c0d61a09cc8deb56e3cae7a9bc3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1277ee1100175cdb8a87ca4e4560a55
publicationDate 2013-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103145663-A
titleOfInvention (S)-2-(2,3-Dihydrobenzofuran-3-yl)acetic acid derivative, its preparation method and its application in medicine
abstract The present invention relates to (S)-2-(2,3-dihydrobenzofuran-3-yl)acetic acid derivatives, their preparation methods, pharmaceutical compositions containing the derivatives and their use as therapeutic agents, especially as GPR40/ Use of FFA1 agonists, specifically providing (S)-2-(2,3-dihydrobenzofuran-3-yl)acetic acid derivatives represented by general formula (I), pharmaceutically acceptable salts or prodrugs thereof . This kind of compound is the agonist of GPR40/FFAR1 receptor, in addition, it also has better prevention and treatment effect on many diseases mediated by GPR40, especially diabetes and the like. Therefore, the compound of the general formula (I) is expected to be developed into a novel drug for treating diabetes and related diseases. The invention also provides a preparation method of the compound.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105418563-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104507921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104193731-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104262330-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105418563-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015062486-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015000412-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104507921-B
priorityDate 2013-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-201245169-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006258722-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008269220-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468015323
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468208366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164132419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465899447
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465596588
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163866862
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72695272
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465051392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID164073694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465986467

Total number of triples: 39.